# A Study of Different Particle Sizes of Evacetrapib in Healthy Participants

> **NCT02497391** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 95 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Evacetrapib

## Key facts

- **NCT ID:** NCT02497391
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2018-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02497391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02497391, "A Study of Different Particle Sizes of Evacetrapib in Healthy Participants". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02497391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*